Skip to main content
Top
Published in: Arthritis Research & Therapy 1/2020

01-12-2020 | Magnetic Resonance Imaging | Research article

Proteoglycan loss in the articular cartilage is associated with severity of joint inflammation in psoriatic arthritis—a compositional magnetic resonance imaging study

Authors: Daniel B. Abrar, Christoph Schleich, Sven Nebelung, Miriam Frenken, Tim Ullrich, Karl Ludger Radke, Gerald Antoch, Stefan Vordenbäumen, Ralph Brinks, Matthias Schneider, Benedikt Ostendorf, Philipp Sewerin

Published in: Arthritis Research & Therapy | Issue 1/2020

Login to get access

Abstract

Background

Even though cartilage loss is a known feature of psoriatic arthritis (PsA), little is known about its role in the pathogenesis of PsA. Using delayed gadolinium-enhanced magnetic resonance imaging of cartilage (dGEMRIC) as a non-invasive marker of the tissue’s proteoglycan content, such early (i.e., pre-morphological) changes have been associated with inflammation in rheumatoid arthritis (RA). Yet, this association has not been studied before in PsA.

Methods

The metacarpophalangeal (MCP), proximal interphalangeal (PIP), and distal interphalangeal (DIP) joints of 17 patients with active PsA were evaluated by high-resolution clinical standard morphological and dGEMRIC sequences using a 3T MRI scanner (Magnetom Skyra, Siemens) and a dedicated 16-channel hand coil. Images were analyzed by two independent raters for dGEMRIC indices, PsA MRI scores (PsAMRIS), and total cartilage thickness (TCT). Kendall tau correlation coefficients (τ) were calculated.

Results

We found significant negative correlations between dGEMRIC indices and total PsAMRIS (τ = − 0.5, p = 0.012), synovitis (τ = − 0.56, p = 0.006), flexor tenosynovitis (τ = − 0.4, p = 0.049), and periarticular inflammation (τ = − 0.72, p < 0.001). Significant positive correlations were found between TCT and dGEMRIC indices at all joint levels (τ = 0.43, p < 0.001). No significant correlations were determined between dGEMRIC indices and bone erosion, bone edema, or bone proliferation.

Conclusion

In PsA, proteoglycan loss as assessed by dGEMRIC is associated with periarticular inflammation, synovitis, and flexor tenosynovitis, but not with bone erosion or proliferation. Thereby, these findings contribute to in vivo concepts of the disease’s pathophysiology. Beyond morphology, advanced MRI techniques may be used to assess cartilage composition in PsA and to identify early changes in the cartilage as an imaging biomarker with potential application in detection, monitoring, and prediction of outcomes of PsA.

Trial registration

2014123117, December 2014.
Literature
1.
go back to reference Sewerin P, Brinks R, Schneider M, et al. Prevalence and incidence of psoriasis and psoriatic arthritis. Ann Rheum Dis. 2019;78(2):286–7.PubMedCrossRef Sewerin P, Brinks R, Schneider M, et al. Prevalence and incidence of psoriasis and psoriatic arthritis. Ann Rheum Dis. 2019;78(2):286–7.PubMedCrossRef
2.
go back to reference Coates LC, Navarro-Coy N, Brown SR, et al. The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis. BMC Musculoskelet Disord. 2013;14:101.PubMedPubMedCentralCrossRef Coates LC, Navarro-Coy N, Brown SR, et al. The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis. BMC Musculoskelet Disord. 2013;14:101.PubMedPubMedCentralCrossRef
3.
go back to reference Singh JA, Guyatt G, Ogdie A, et al. Special article: 2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis. Arthritis Care Res (Hoboken). 2019;71(1):2–29.CrossRef Singh JA, Guyatt G, Ogdie A, et al. Special article: 2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis. Arthritis Care Res (Hoboken). 2019;71(1):2–29.CrossRef
4.
5.
go back to reference Coates LC, Lubrano E, Perrotta FM, et al. What should be the primary target of “treat to target” in psoriatic arthritis? J Rheumatol. 2019;46(1):38–42.PubMedCrossRef Coates LC, Lubrano E, Perrotta FM, et al. What should be the primary target of “treat to target” in psoriatic arthritis? J Rheumatol. 2019;46(1):38–42.PubMedCrossRef
6.
go back to reference Colebatch AN, Edwards CJ, Østergaard M, et al. EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis. 2013;72(6):804–14.PubMedCrossRef Colebatch AN, Edwards CJ, Østergaard M, et al. EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis. 2013;72(6):804–14.PubMedCrossRef
7.
go back to reference Sudoł-Szopińska I, Matuszewska G, Kwiatkowska B, et al. Diagnostic imaging of psoriatic arthritis. Part I: etiopathogenesis, classifications and radiographic features. J Ultrason. 2016;16(64):65–77.PubMedPubMedCentralCrossRef Sudoł-Szopińska I, Matuszewska G, Kwiatkowska B, et al. Diagnostic imaging of psoriatic arthritis. Part I: etiopathogenesis, classifications and radiographic features. J Ultrason. 2016;16(64):65–77.PubMedPubMedCentralCrossRef
8.
go back to reference Sudoł-Szopińska I, Płaza M, Pracoń G. Selected issues in diagnostic imaging of spondyloarthritides: psoriatic arthritis and juvenile spondyloarthritis. Reumatologia. 2016;54(6):310–7.PubMedPubMedCentralCrossRef Sudoł-Szopińska I, Płaza M, Pracoń G. Selected issues in diagnostic imaging of spondyloarthritides: psoriatic arthritis and juvenile spondyloarthritis. Reumatologia. 2016;54(6):310–7.PubMedPubMedCentralCrossRef
9.
go back to reference Møller-Bisgaard S, Hørslev-Petersen K, Ejbjerg BJ, et al. Impact of a magnetic resonance imaging-guided treat-to-target strategy on disease activity and progression in patients with rheumatoid arthritis (the IMAGINE-RA trial): study protocol for a randomized controlled trial. Trials. 2015;16:178.PubMedPubMedCentralCrossRef Møller-Bisgaard S, Hørslev-Petersen K, Ejbjerg BJ, et al. Impact of a magnetic resonance imaging-guided treat-to-target strategy on disease activity and progression in patients with rheumatoid arthritis (the IMAGINE-RA trial): study protocol for a randomized controlled trial. Trials. 2015;16:178.PubMedPubMedCentralCrossRef
10.
go back to reference Coates LC, Conaghan PG, D’Agostino MA, et al. Remission in psoriatic arthritis-where are we now? Rheumatology (Oxford). 2018;57(8):1321–31.CrossRef Coates LC, Conaghan PG, D’Agostino MA, et al. Remission in psoriatic arthritis-where are we now? Rheumatology (Oxford). 2018;57(8):1321–31.CrossRef
11.
go back to reference Yue J, Wu D, Tam L-S. The role of imaging in early diagnosis and prevention of joint damage in inflammatory arthritis. Expert Rev Clin Immunol. 2018;14(6):499–511 (accessed 26 Apr 2019).PubMedCrossRef Yue J, Wu D, Tam L-S. The role of imaging in early diagnosis and prevention of joint damage in inflammatory arthritis. Expert Rev Clin Immunol. 2018;14(6):499–511 (accessed 26 Apr 2019).PubMedCrossRef
12.
go back to reference Ostergaard M, McQueen F, Wiell C, et al. The OMERACT psoriatic arthritis magnetic resonance imaging scoring system (PsAMRIS): definitions of key pathologies, suggested MRI sequences, and preliminary scoring system for PsA hands. J Rheumatol. 2009;36(8):1816–24.PubMedCrossRef Ostergaard M, McQueen F, Wiell C, et al. The OMERACT psoriatic arthritis magnetic resonance imaging scoring system (PsAMRIS): definitions of key pathologies, suggested MRI sequences, and preliminary scoring system for PsA hands. J Rheumatol. 2009;36(8):1816–24.PubMedCrossRef
13.
go back to reference Møller-Bisgaard S, Hørslev-Petersen K, Ejbjerg B, et al. Effect of magnetic resonance imaging vs conventional treat-to-target strategies on disease activity remission and radiographic progression in rheumatoid arthritis: the IMAGINE-RA Randomized Clinical Trial. JAMA. 2019;321(5):461–72.PubMedPubMedCentralCrossRef Møller-Bisgaard S, Hørslev-Petersen K, Ejbjerg B, et al. Effect of magnetic resonance imaging vs conventional treat-to-target strategies on disease activity remission and radiographic progression in rheumatoid arthritis: the IMAGINE-RA Randomized Clinical Trial. JAMA. 2019;321(5):461–72.PubMedPubMedCentralCrossRef
14.
go back to reference Bridges SL. Personalized medicine in rheumatoid arthritis: hopes and challenges. Bull NYU Hosp Jt Dis. 2007;65(3):174–7.PubMed Bridges SL. Personalized medicine in rheumatoid arthritis: hopes and challenges. Bull NYU Hosp Jt Dis. 2007;65(3):174–7.PubMed
15.
go back to reference Conaghan PG, Østergaard M, Troum O, et al. Very early MRI responses to therapy as a predictor of later radiographic progression in early rheumatoid arthritis. Arthritis Res Ther. 2019;21(1):214.PubMedPubMedCentralCrossRef Conaghan PG, Østergaard M, Troum O, et al. Very early MRI responses to therapy as a predictor of later radiographic progression in early rheumatoid arthritis. Arthritis Res Ther. 2019;21(1):214.PubMedPubMedCentralCrossRef
16.
go back to reference Sewerin P, Le L, Vordenbäumen S, et al. Rheumatoid arthritis magnetic resonance imaging score predicts therapy response: results of the German ArthroMark Cohort. J Rheumatol. 2018;45(6):753–9.PubMedCrossRef Sewerin P, Le L, Vordenbäumen S, et al. Rheumatoid arthritis magnetic resonance imaging score predicts therapy response: results of the German ArthroMark Cohort. J Rheumatol. 2018;45(6):753–9.PubMedCrossRef
17.
go back to reference Bhattaram P, Chandrasekharan U. The joint synovium: a critical determinant of articular cartilage fate in inflammatory joint diseases. Semin Cell Dev Biol. 2017;62:86–93 (accessed 26 Apr 2019).PubMedCrossRef Bhattaram P, Chandrasekharan U. The joint synovium: a critical determinant of articular cartilage fate in inflammatory joint diseases. Semin Cell Dev Biol. 2017;62:86–93 (accessed 26 Apr 2019).PubMedCrossRef
18.
go back to reference Østergaard M, Peterfy CG, Bird P, et al. The OMERACT rheumatoid arthritis magnetic resonance imaging (MRI) scoring system: updated recommendations by the OMERACT MRI in Arthritis Working Group. J Rheumatol. 2017;44(11):1706–12.PubMedCrossRef Østergaard M, Peterfy CG, Bird P, et al. The OMERACT rheumatoid arthritis magnetic resonance imaging (MRI) scoring system: updated recommendations by the OMERACT MRI in Arthritis Working Group. J Rheumatol. 2017;44(11):1706–12.PubMedCrossRef
19.
go back to reference Bartosińska J, Michalak-Stoma A, Juszkiewicz-Borowiec M, et al. The assessment of selected bone and cartilage biomarkers in psoriatic patients from Poland. Mediat Inflamm. 2015;2015:194535 (accessed 26 Apr 2019).CrossRef Bartosińska J, Michalak-Stoma A, Juszkiewicz-Borowiec M, et al. The assessment of selected bone and cartilage biomarkers in psoriatic patients from Poland. Mediat Inflamm. 2015;2015:194535 (accessed 26 Apr 2019).CrossRef
20.
go back to reference Chandran V, Abji F, Perruccio AV, et al. Serum-based soluble markers differentiate psoriatic arthritis from osteoarthritis. Ann Rheum Dis. 2019; (accessed 26 Apr 2019). Chandran V, Abji F, Perruccio AV, et al. Serum-based soluble markers differentiate psoriatic arthritis from osteoarthritis. Ann Rheum Dis. 2019; (accessed 26 Apr 2019).
21.
go back to reference Farouk HM, Mostafa AAA, Youssef SS, et al. Value of entheseal ultrasonography and serum cartilage oligomeric matrix protein in the preclinical diagnosis of psoriatic arthritis. Clin Med Insights Arthritis Musculoskelet Disord. 2010;3:7–14.PubMedPubMedCentralCrossRef Farouk HM, Mostafa AAA, Youssef SS, et al. Value of entheseal ultrasonography and serum cartilage oligomeric matrix protein in the preclinical diagnosis of psoriatic arthritis. Clin Med Insights Arthritis Musculoskelet Disord. 2010;3:7–14.PubMedPubMedCentralCrossRef
22.
go back to reference McGonagle D, Tan AL, Møller Døhn U, et al. Microanatomic studies to define predictive factors for the topography of periarticular erosion formation in inflammatory arthritis. Arthritis Rheum. 2009;60(4):1042–51.PubMedCrossRef McGonagle D, Tan AL, Møller Døhn U, et al. Microanatomic studies to define predictive factors for the topography of periarticular erosion formation in inflammatory arthritis. Arthritis Rheum. 2009;60(4):1042–51.PubMedCrossRef
23.
go back to reference McGonagle D, Tan AL. The enthesis in psoriatic arthritis. Clin Exp Rheumatol. 2015;33(5 Suppl 93):S36–9.PubMed McGonagle D, Tan AL. The enthesis in psoriatic arthritis. Clin Exp Rheumatol. 2015;33(5 Suppl 93):S36–9.PubMed
24.
go back to reference McGonagle D, Lories RJU, Tan AL, et al. The concept of a “synovio-entheseal complex” and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond. Arthritis Rheum. 2007;56(8):2482–91.PubMedCrossRef McGonagle D, Lories RJU, Tan AL, et al. The concept of a “synovio-entheseal complex” and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond. Arthritis Rheum. 2007;56(8):2482–91.PubMedCrossRef
25.
go back to reference Miese FR, Ostendorf B, Wittsack H-J, et al. Metacarpophalangeal joints in rheumatoid arthritis: delayed gadolinium-enhanced MR imaging of cartilage--a feasibility study. Radiology. 2010;257(2):441–7.PubMedCrossRef Miese FR, Ostendorf B, Wittsack H-J, et al. Metacarpophalangeal joints in rheumatoid arthritis: delayed gadolinium-enhanced MR imaging of cartilage--a feasibility study. Radiology. 2010;257(2):441–7.PubMedCrossRef
26.
go back to reference Miese F, Buchbender C, Scherer A, et al. Molecular imaging of cartilage damage of finger joints in early rheumatoid arthritis with delayed gadolinium-enhanced magnetic resonance imaging. Arthritis Rheum. 2012;64(2):394–9.PubMedCrossRef Miese F, Buchbender C, Scherer A, et al. Molecular imaging of cartilage damage of finger joints in early rheumatoid arthritis with delayed gadolinium-enhanced magnetic resonance imaging. Arthritis Rheum. 2012;64(2):394–9.PubMedCrossRef
27.
go back to reference Bashir A, Gray ML, Hartke J, et al. Nondestructive imaging of human cartilage glycosaminoglycan concentration by MRI. Magn Reson Med. 1999;41(5):857–65.PubMedCrossRef Bashir A, Gray ML, Hartke J, et al. Nondestructive imaging of human cartilage glycosaminoglycan concentration by MRI. Magn Reson Med. 1999;41(5):857–65.PubMedCrossRef
28.
go back to reference Zilkens C, Miese F, Herten M, et al. Validity of gradient-echo three-dimensional delayed gadolinium-enhanced magnetic resonance imaging of hip joint cartilage: a histologically controlled study. Eur J Radiol. 2013;82(2):e81–6.PubMedCrossRef Zilkens C, Miese F, Herten M, et al. Validity of gradient-echo three-dimensional delayed gadolinium-enhanced magnetic resonance imaging of hip joint cartilage: a histologically controlled study. Eur J Radiol. 2013;82(2):e81–6.PubMedCrossRef
29.
go back to reference Herz B, Albrecht A, Englbrecht M, et al. Osteitis and synovitis, but not bone erosion, is associated with proteoglycan loss and microstructure damage in the cartilage of patients with rheumatoid arthritis. Ann Rheum Dis. 2014;73(6):1101–6.PubMedCrossRef Herz B, Albrecht A, Englbrecht M, et al. Osteitis and synovitis, but not bone erosion, is associated with proteoglycan loss and microstructure damage in the cartilage of patients with rheumatoid arthritis. Ann Rheum Dis. 2014;73(6):1101–6.PubMedCrossRef
30.
go back to reference Sewerin P, Müller-Lutz A, Abrar DB, et al. Prevention of the progressive biochemical cartilage destruction under methotrexate therapy in early rheumatoid arthritis. Clin Exp Rheumatol. 2019;37(2):179–85.PubMed Sewerin P, Müller-Lutz A, Abrar DB, et al. Prevention of the progressive biochemical cartilage destruction under methotrexate therapy in early rheumatoid arthritis. Clin Exp Rheumatol. 2019;37(2):179–85.PubMed
31.
go back to reference Schleich C, Müller-Lutz A, Sewerin P, et al. Intra-individual assessment of inflammatory severity and cartilage composition of finger joints in rheumatoid arthritis. Skelet Radiol. 2015;44(4):513–8.CrossRef Schleich C, Müller-Lutz A, Sewerin P, et al. Intra-individual assessment of inflammatory severity and cartilage composition of finger joints in rheumatoid arthritis. Skelet Radiol. 2015;44(4):513–8.CrossRef
32.
go back to reference Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54(8):2665–73.PubMedCrossRef Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54(8):2665–73.PubMedCrossRef
33.
go back to reference Miese F, Kröpil P, Ostendorf B, et al. Motion correction improves image quality of dGEMRIC in finger joints. Eur J Radiol. 2011;80(3):e427–31.PubMed Miese F, Kröpil P, Ostendorf B, et al. Motion correction improves image quality of dGEMRIC in finger joints. Eur J Radiol. 2011;80(3):e427–31.PubMed
34.
go back to reference Miese FR, Ostendorf B, Wittsack H-J, et al. Knorpelqualität an den Fingergelenken: delayed Gd (DTPA)2-enhanced MRI of the cartilage (dGEMRIC) bei 3T. Rofo. 2010;182(10):873–8.PubMedCrossRef Miese FR, Ostendorf B, Wittsack H-J, et al. Knorpelqualität an den Fingergelenken: delayed Gd (DTPA)2-enhanced MRI of the cartilage (dGEMRIC) bei 3T. Rofo. 2010;182(10):873–8.PubMedCrossRef
36.
38.
go back to reference Zabotti A, Salvin S, Quartuccio L, et al. Differentiation between early rheumatoid and early psoriatic arthritis by the ultrasonographic study of the synovio-entheseal complex of the small joints of the hands. Clin Exp Rheumatol. 2016;34(3):459–65.PubMed Zabotti A, Salvin S, Quartuccio L, et al. Differentiation between early rheumatoid and early psoriatic arthritis by the ultrasonographic study of the synovio-entheseal complex of the small joints of the hands. Clin Exp Rheumatol. 2016;34(3):459–65.PubMed
39.
go back to reference Sudoł-Szopińska I, Pracoń G. Diagnostic imaging of psoriatic arthritis. Part II: magnetic resonance imaging and ultrasonography. J Ultrason. 2016;16(65):163–74.PubMedPubMedCentralCrossRef Sudoł-Szopińska I, Pracoń G. Diagnostic imaging of psoriatic arthritis. Part II: magnetic resonance imaging and ultrasonography. J Ultrason. 2016;16(65):163–74.PubMedPubMedCentralCrossRef
40.
go back to reference Sudoł-Szopińska I, Kontny E, Maśliński W, et al. Significance of bone marrow edema in pathogenesis of rheumatoid arthritis. Pol J Radiol. 2013;78(1):57–63.PubMedPubMedCentralCrossRef Sudoł-Szopińska I, Kontny E, Maśliński W, et al. Significance of bone marrow edema in pathogenesis of rheumatoid arthritis. Pol J Radiol. 2013;78(1):57–63.PubMedPubMedCentralCrossRef
41.
go back to reference Sudoł-Szopińska I, Kwiatkowska B, Prochorec-Sobieszek M, et al. Enthesopathies and enthesitis. Part 1. Etiopathogenesis. J Ultrason. 2015;15(60):72–84.PubMedPubMedCentralCrossRef Sudoł-Szopińska I, Kwiatkowska B, Prochorec-Sobieszek M, et al. Enthesopathies and enthesitis. Part 1. Etiopathogenesis. J Ultrason. 2015;15(60):72–84.PubMedPubMedCentralCrossRef
42.
go back to reference Kaeley GS, Eder L, Aydin SZ, et al. Dactylitis: a hallmark of psoriatic arthritis. Semin Arthritis Rheum. 2018;48(2):263–73.PubMedCrossRef Kaeley GS, Eder L, Aydin SZ, et al. Dactylitis: a hallmark of psoriatic arthritis. Semin Arthritis Rheum. 2018;48(2):263–73.PubMedCrossRef
43.
go back to reference Kaeley GS, Eder L, Aydin SZ, et al. Enthesitis: a hallmark of psoriatic arthritis. Semin Arthritis Rheum. 2018;48(1):35–43.PubMedCrossRef Kaeley GS, Eder L, Aydin SZ, et al. Enthesitis: a hallmark of psoriatic arthritis. Semin Arthritis Rheum. 2018;48(1):35–43.PubMedCrossRef
44.
go back to reference Tan AL, Fukuba E, Halliday NA, et al. High-resolution MRI assessment of dactylitis in psoriatic arthritis shows flexor tendon pulley and sheath-related enthesitis. Ann Rheum Dis. 2015;74(1):185–9.PubMedCrossRef Tan AL, Fukuba E, Halliday NA, et al. High-resolution MRI assessment of dactylitis in psoriatic arthritis shows flexor tendon pulley and sheath-related enthesitis. Ann Rheum Dis. 2015;74(1):185–9.PubMedCrossRef
45.
go back to reference Aletaha D, Funovits J, Smolen JS. Physical disability in rheumatoid arthritis is associated with cartilage damage rather than bone destruction. Ann Rheum Dis. 2011;70(5):733–9.PubMedCrossRef Aletaha D, Funovits J, Smolen JS. Physical disability in rheumatoid arthritis is associated with cartilage damage rather than bone destruction. Ann Rheum Dis. 2011;70(5):733–9.PubMedCrossRef
46.
go back to reference Hayer S, Bauer G, Willburger M, et al. Cartilage damage and bone erosion are more prominent determinants of functional impairment in longstanding experimental arthritis than synovial inflammation. Dis Model Mech. 2016;9(11):1329–38 (accessed 8 May 2019).PubMedPubMedCentralCrossRef Hayer S, Bauer G, Willburger M, et al. Cartilage damage and bone erosion are more prominent determinants of functional impairment in longstanding experimental arthritis than synovial inflammation. Dis Model Mech. 2016;9(11):1329–38 (accessed 8 May 2019).PubMedPubMedCentralCrossRef
47.
go back to reference FitzGerald O, Chandran V. Update on biomarkers in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting. J Rheumatol. 2012;39(2):427–30.PubMedCrossRef FitzGerald O, Chandran V. Update on biomarkers in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting. J Rheumatol. 2012;39(2):427–30.PubMedCrossRef
48.
go back to reference FitzGerald O, Mease PJ. Biomarkers: project update from the GRAPPA 2012 annual meeting. J Rheumatol. 2013;40(8):1453–4.PubMedCrossRef FitzGerald O, Mease PJ. Biomarkers: project update from the GRAPPA 2012 annual meeting. J Rheumatol. 2013;40(8):1453–4.PubMedCrossRef
49.
go back to reference Ramonda R, Modesti V, Ortolan A, et al. Serological markers in psoriatic arthritis: promising tools. Exp Biol Med (Maywood). 2013;238(12):1431–6.CrossRef Ramonda R, Modesti V, Ortolan A, et al. Serological markers in psoriatic arthritis: promising tools. Exp Biol Med (Maywood). 2013;238(12):1431–6.CrossRef
50.
go back to reference Karsdal MA, Madsen SH, Christiansen C, et al. Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity. Arthritis Res Ther. 2008;10(3):R63.PubMedPubMedCentralCrossRef Karsdal MA, Madsen SH, Christiansen C, et al. Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity. Arthritis Res Ther. 2008;10(3):R63.PubMedPubMedCentralCrossRef
51.
go back to reference Tan AL, Grainger AJ, Tanner SF, et al. A high-resolution magnetic resonance imaging study of distal interphalangeal joint arthropathy in psoriatic arthritis and osteoarthritis: are they the same? Arthritis Rheum. 2006;54(4):1328–33.PubMedCrossRef Tan AL, Grainger AJ, Tanner SF, et al. A high-resolution magnetic resonance imaging study of distal interphalangeal joint arthropathy in psoriatic arthritis and osteoarthritis: are they the same? Arthritis Rheum. 2006;54(4):1328–33.PubMedCrossRef
52.
go back to reference Ramonda R, Favero M, Vio S, et al. A recently developed MRI scoring system for hand osteoarthritis: its application in a clinical setting. Clin Rheumatol. 2016;35(8):2079–86.PubMedCrossRef Ramonda R, Favero M, Vio S, et al. A recently developed MRI scoring system for hand osteoarthritis: its application in a clinical setting. Clin Rheumatol. 2016;35(8):2079–86.PubMedCrossRef
53.
go back to reference Haugen IK, Eshed I, Gandjbakhch F, et al. The longitudinal reliability and responsiveness of the OMERACT Hand Osteoarthritis Magnetic Resonance Imaging Scoring System (HOAMRIS). J Rheumatol. 2015;42(12):2486–91.PubMedCrossRef Haugen IK, Eshed I, Gandjbakhch F, et al. The longitudinal reliability and responsiveness of the OMERACT Hand Osteoarthritis Magnetic Resonance Imaging Scoring System (HOAMRIS). J Rheumatol. 2015;42(12):2486–91.PubMedCrossRef
54.
go back to reference Haugen IK, Lillegraven S, Slatkowsky-Christensen B, et al. Hand osteoarthritis and MRI: development and first validation step of the proposed Oslo hand osteoarthritis MRI score. Ann Rheum Dis. 2011;70(6):1033–8.PubMedCrossRef Haugen IK, Lillegraven S, Slatkowsky-Christensen B, et al. Hand osteoarthritis and MRI: development and first validation step of the proposed Oslo hand osteoarthritis MRI score. Ann Rheum Dis. 2011;70(6):1033–8.PubMedCrossRef
55.
go back to reference McGonagle D, Hermann K-GA, Tan AL. Differentiation between osteoarthritis and psoriatic arthritis: implications for pathogenesis and treatment in the biologic therapy era. Rheumatology (Oxford). 2015;54(1):29–38.CrossRef McGonagle D, Hermann K-GA, Tan AL. Differentiation between osteoarthritis and psoriatic arthritis: implications for pathogenesis and treatment in the biologic therapy era. Rheumatology (Oxford). 2015;54(1):29–38.CrossRef
56.
go back to reference Sanz R, Martí-Bonmatí L, Rodrigo JL, et al. MR pharmacokinetic modeling of the patellar cartilage differentiates normal from pathological conditions. J Magn Reson Imaging. 2008;27(1):171–7.PubMedCrossRef Sanz R, Martí-Bonmatí L, Rodrigo JL, et al. MR pharmacokinetic modeling of the patellar cartilage differentiates normal from pathological conditions. J Magn Reson Imaging. 2008;27(1):171–7.PubMedCrossRef
57.
go back to reference Raczeck P, Fries P, Bücker A, et al. Gadoliniumablagerungen – Morbus Gadolinium. Radiologe. 2019;59(5):435–43.PubMedCrossRef Raczeck P, Fries P, Bücker A, et al. Gadoliniumablagerungen – Morbus Gadolinium. Radiologe. 2019;59(5):435–43.PubMedCrossRef
Metadata
Title
Proteoglycan loss in the articular cartilage is associated with severity of joint inflammation in psoriatic arthritis—a compositional magnetic resonance imaging study
Authors
Daniel B. Abrar
Christoph Schleich
Sven Nebelung
Miriam Frenken
Tim Ullrich
Karl Ludger Radke
Gerald Antoch
Stefan Vordenbäumen
Ralph Brinks
Matthias Schneider
Benedikt Ostendorf
Philipp Sewerin
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/2020
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/s13075-020-02219-7

Other articles of this Issue 1/2020

Arthritis Research & Therapy 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.